Your browser doesn't support javascript.
loading
The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo.
Khan, Atif J; LaCava, Stephanie; Mehta, Monal; Schiff, Devora; Thandoni, Aditya; Jhawar, Sachin; Danish, Shabbar; Haffty, Bruce G; Chen, Suzie.
Affiliation
  • Khan AJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
  • LaCava S; Department of Radiation Oncology, Rutgers-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
  • Mehta M; Department of Radiation Oncology, Rutgers-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
  • Schiff D; Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA.
  • Thandoni A; Department of Radiation Oncology, Rutgers-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
  • Jhawar S; Department of Radiation Oncology, Rutgers-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
  • Danish S; Department of Radiation Oncology, Rutgers-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
  • Haffty BG; Department of Radiation Oncology, Rutgers-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
  • Chen S; Department of Surgery, Division of Neurosurgery, Rutgers-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
Oncotarget ; 10(29): 2824-2834, 2019 Apr 19.
Article in En | MEDLINE | ID: mdl-31073373

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2019 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2019 Document type: Article Affiliation country: United States Country of publication: United States